Catalyst Oncology Consulting is focused solely on the development of new treatments in oncology. Catalyst Oncology Consulting provides a unified expert platform to support biotech companies through all phases of development from lead optimization through NDA. We partner with clients to effectively develop their assets by utilizing the best emerging science and regulatory support to improve cancer diagnosis and treatment
Services we offer
- Drug Development Strategy Workshops provide a unified framework to assess risk, identify gaps and lay out an optimum development pathway for FIH or investor targets
- Flexible Access to highly experienced regulatory, preclinical, toxicology, pharmaceutical development partners and oncology SMEs.
- Bespoke Consulting Project Teams offer an integrated collaboration to support clients’ key milestones and provide flexible, complementary knowledge and resources
“Catalyst clearly demonstrated they have the expertise and connections to evaluate this scenario thoroughly. They were very easy to work with and the quality of the output we received, together with its speed, was impressive.”
Industry-leading experts
Offering the opportunity to assemble experts and partners, with an average of 20 years experience, to
advise clients on minimum & optimal development pathways, including:
- Pharmaceutical development
- Biomarker development
- CMC
- Medical writing
- Pharmaceutical physicians
- Biostatisticians
- Medical scientists
- Translational scientists
- Regulatory experts
- PD/PK experts
- Toxicologists
- Clinical operations/Clinical oncologists
We are your partners in product development, serving as an extension of your study team
“A fabulous job – many thanks all. A clear basis around which to plan our transition from discovery to development.
We can help
- Develop and deliver optimized drug development plans to deliver the best asset to patients and investors
- Deliver a gap analysis report to frame an asset’s technical, clinical and commercial risks and likelihood of success
- Assess the challenges and unique questions through a unified SME platform
